IBM (IBM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Apr, 2026Executive summary
Achieved 6% revenue growth in 2025, reaching $67.5B, and $14.7B free cash flow, both the highest in over a decade, with double-digit growth in Software and Infrastructure and robust adoption of next-gen mainframe platforms.
Software now represents 45% of business, up from 25% in 2018, with 9% annual growth and three sub-segments at double-digit growth; generative AI book of business surpassed $12.5B.
Infrastructure revenue up 17% in Q4, driven by IBM Z, which had its best annual revenue in 20 years and record quarterly performance.
Consulting returned to growth in the second half, with GenAI book of business surpassing $12.5B and Intelligent Operations up 3%.
Exceeded all target metrics for revenue, profitability, and free cash flow set at Investor Day.
Financial highlights
FY25 revenue was $67.5B, up 6%; Q4 revenue reached $19.7B, up 12% year-over-year; free cash flow was $14.7B, up 16% year-over-year.
Adjusted EBITDA grew 17% to $19.2B; operating diluted EPS rose 12% to $11.59; net income for Q4 was $5.6B, up 91% year-over-year.
Operating pre-tax margin expanded by 100bps; gross profit margin for FY25 was 59.5%, up 1.7 pts.
ARR was $23.6B, up over $2B from 2024.
Segment profit margins expanded: software +100bps, consulting +180bps, infrastructure +450bps.
Outlook and guidance
2026 guidance: over 5% constant currency revenue growth, ~$1B increase in free cash flow, and 1 point operating pre-tax margin expansion.
Software expected to grow 10% in 2026, led by organic growth and M&A synergies.
Consulting revenue to accelerate to low- to mid-single digits, with GenAI backlog penetration over 25%.
Infrastructure revenue expected to decline low single digits due to product cycle dynamics.
Confluent acquisition expected to close mid-2026, with $600M dilution in 2026, accretive to EBITDA in year one and free cash flow in year two.
Latest events from IBM
- Board urges support for key proposals and highlights strong growth, innovation, and governance.IBM
Proxy filing8 Apr 2026 - Board recommends all management proposals, opposes all shareholder proposals, and highlights strong growth.IBM
Proxy Filing10 Mar 2026 - Director elections, executive pay, auditor ratification, and ESG proposals headline the 2026 meeting.IBM
Proxy Filing10 Mar 2026 - Strong financials, AI and quantum focus, and all board items passed except lobbying transparency.IBM
AGM 20253 Feb 2026 - Q2 revenue up to $15.8B; free cash flow guidance raised above $12B for 2024.IBM
Q2 20243 Feb 2026 - Hybrid cloud, AI, and GenAI platforms drive growth, margin, and cash flow expansion.IBM
Goldman Sachs Communacopia + Technology Conference 202421 Jan 2026 - AI and automation drive major cost savings and risk reduction in cybersecurity operations.IBM
Status Update19 Jan 2026 - Q3 Software growth hit 10%, free cash flow surged, but a pension charge led to a net loss.IBM
Q3 202419 Jan 2026 - Record free cash flow and double-digit software growth set up at least 5% revenue gains in 2025.IBM
Q4 20249 Jan 2026